Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedRecruitment status changed from Recruiting to Completed, with the update posted on 2025-12-05.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page update shows a new revision number (v3.3.2) without visible changes to the study details or related information.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check32 days agoChange DetectedThe notice about government funding and NIH operating status has been removed. The main study details, eligibility, locations, and contacts remain unchanged.SummaryDifference0.3%

- Check39 days agoChange DetectedNon-significant administrative updates were observed (e.g., last update date and formatting) with no changes to core content, eligibility criteria, endpoints, or recruitment scope. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Specialty Clinical Research of St Louis as a recruitment site, bringing total locations to 60, and updated Part 4 outcome descriptions and baseline visit timepoints.SummaryDifference0.8%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.